newsroompost
  • youtube
  • facebook
  • twitter
  1. Home

  2. Tag: Covaxin

India’s Covid case tally crosses 34 lakh mark with spike of 76,472 new cases in 24 hrs

India’s Covid case tally crosses 34 lakh mark with spike of 76,472 new cases in 24 hrs

 Newsroom Staff
India’s first COVID-19 vaccine Covaxin to be available by the end of 2020: Dr Harsh Vardhan

India’s first COVID-19 vaccine Covaxin to be available by the end of 2020: Dr Harsh Vardhan

 Newsroom Staff
Phase-2 trial of indigenously developed Covaxin begins in Nagpur

Phase-2 trial of indigenously developed Covaxin begins in Nagpur

 Newsroom Staff
With spike of 52,050 cases, India’s COVID-19 tally reaches 18,55,746

With spike of 52,050 cases, India’s COVID-19 tally reaches 18,55,746

 Newsroom Staff
First part of phase-1 of Covaxin human trial completed at PGI Rohtak

First part of phase-1 of Covaxin human trial completed at PGI Rohtak

 Newsroom Staff
COVID-19: AIIMS to start clinical trial of indigenous vaccine Covaxin from today

COVID-19: AIIMS to start clinical trial of indigenous vaccine Covaxin from today

 Newsroom Staff
Delhi rains: Body found under waterlogged Minto Bridge

Delhi rains: Body found under waterlogged Minto Bridge

 Newsroom Staff
COVID-19: AIIMS to start clinical trial of indigenous vaccine Covaxin from Monday

COVID-19: AIIMS to start clinical trial of indigenous vaccine Covaxin from Monday

 Neha Singh
Good News: Human trial of COVAXIN, India’s first Covid-19 vaccine begins at AIIMS-Patna

Good News: Human trial of COVAXIN, India’s first Covid-19 vaccine begins at AIIMS-Patna

 Newsroom Staff
Covaxin: Human trials of India’s first Covid-19 vaccine on 375 people to begin soon

Covaxin: Human trials of India’s first Covid-19 vaccine on 375 people to begin soon

 Newsroom Staff

What's New

Don't Miss

newsroompost

About Us

This site is run and owned by Headlong NewsroomPost India Private Limited.

Quick Link

 

Important Link

© 2024, All Rights Reserved by Headlong Newsroom Post India Private Limited